Herd Immunity to the Measles, Mumps and Rubella Viruses Among the Belgradian Population in May, 2024
<b>Background/Objectives:</b> In the Republic of Serbia, measles vaccination was first introduced in 1971, while combined vaccination (measles, mumps, rubella) was made mandatory in 1996 as part of the national vaccination program. Reported prevalence values for 2023 were <0.75 cases...
Saved in:
Main Authors: | Anna Y. Popova, Vyacheslav S. Smirnov, Svetlana A. Egorova, Luka Dragačević, Angelica M. Milichkina, Jelena Protić, Ekaterina M. Danilova, Irina V. Drozd, Marija Petrušić, Ojuna B. Zhimbaeva, Elizaveta S. Glazkova, Nataša Gutić, Valeri A. Ivanov, Edward S. Ramsay, Oleg V. Kotsar, Vyacheslav Y. Smolensky, Areg A. Totolian |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/13/6/652 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Domestic Tetravaccine (Measles-Rubella-Mumps) – Immunization of Premature Babies
by: V. V. Semerikov, et al.
Published: (2022-09-01) -
Characteristics of the epidemic process of measles, rubella and mumps in Moscow and assessment of their seroprevalence at the present stage
by: Yana V. Simakova, et al.
Published: (2025-04-01) -
Seroprevalence of Measles-, Mumps-, and Rubella-Specific Antibodies in Future Healthcare Workers in Serbia: A Cross-Sectional Study
by: Ana Banko, et al.
Published: (2025-06-01) -
Safety of antibodies to measles, mumps, rubella and diphtheria in patients with juvenile idiopathic arthritis
by: I. V. Fridman, et al.
Published: (2021-07-01) -
Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir<sup>®</sup> in children 12 months and 6 years of age (results of a simple blind multicenter comparative randomized clinical trial)
by: I. V. Feldblium, et al.
Published: (2021-03-01)